Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares RepurchasedShort-Term Debt repayments
Ratios

Bio-Techne (TECH) Leases (2019 - 2025)

Bio-Techne has reported Leases over the past 7 years, most recently at $68.2 million for Q4 2025.

  • Quarterly results put Leases at $68.2 million for Q4 2025, down 20.07% from a year ago — trailing twelve months through Dec 2025 was $68.2 million (down 20.07% YoY), and the annual figure for FY2025 was $73.4 million, down 19.59%.
  • Leases for Q4 2025 was $68.2 million at Bio-Techne, down from $70.7 million in the prior quarter.
  • Over the last five years, Leases for TECH hit a ceiling of $102.3 million in Q3 2023 and a floor of $63.4 million in Q1 2022.
  • Median Leases over the past 5 years was $78.8 million (2021), compared with a mean of $81.1 million.
  • Biggest five-year swings in Leases: skyrocketed 54.41% in 2023 and later fell 20.73% in 2025.
  • Bio-Techne's Leases stood at $64.3 million in 2021, then skyrocketed by 30.55% to $83.9 million in 2022, then increased by 20.17% to $100.9 million in 2023, then fell by 15.35% to $85.4 million in 2024, then dropped by 20.07% to $68.2 million in 2025.
  • The last three reported values for Leases were $68.2 million (Q4 2025), $70.7 million (Q3 2025), and $73.4 million (Q2 2025) per Business Quant data.